View Older Stories View More Recent Stories
-
Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range
-
Activity of ISIS 560131/AZD5321 (ISIS) 'Incredibly Exciting' - BMO Capital
-
AGTC Announces Pricing of Initial Public Offering
-
TubeMogul (TUBE) Files $75 Million IPO
-
King Digital Entertainment (KING) IPO Opens Lower
-
BMO Capital Positive on ARIAD Pharmaceuticals (ARIA) on Initiation of AP26113 Pivotal Study
-
King Digital Entertainment (KING) IPO Priced at $22.50/Share
-
Cloud Collaboration Platform Provider Box, Inc. (BOX) Files for $250M IPO
-
Stocks Weaker, Led by High-Beta Names
-
Notable Analyst Rating Changes 03/24: (BBRY) (BSX) (YELP) Upgraded; (ZION) (TIF) (WTSL) Downgraded
-
BMO Capital Downgrades Zions Bancorp (ZION) to Market Perform
-
BMO Capital Upgrades Symantec (SYMC) to Outperform
-
BMO Capital Downgrades BBCN Bancorp (BBCN) to Market Perform
-
GrubHub (GRUB) Sees IPO Price of $20 to $22/Share
-
VMware (VMW) Target, Estimates Lifted at BMO Capital
-
EMC (EMC) Price Target Lifted at BMO Capital
-
Fate Therapeutics (FATE) Target Price Lifted at BMO Capital
-
MediWound Ltd. (MDWD) IPO Opens Sharply Higher
-
MediWound (MDWD) IPO Prices at Low End of Range
-
BMO Capital Starts Pioneer Natural Resources (PXD) at Market Perform
-
BMO Capital Upgrades Flowers Foods (FLO) to Outperform
-
Intercept (ICPT) Positive POISE Trial Helps Balance FLINT CV Risk, BMO Capital Says
-
BMO Capital Downgrades EPL Oil & Gas (EPL) to Market Perform
-
Post Holdings (POST) Prices Larger 5M Common Offering at $55/Share; Prices Notes Offering
-
BMO Capital Downgrades Synta Pharma. (SNTA) to Underperform
-
King Digital Ent. (KING) Sees IPO Price of $21 - $24/Share
-
Virtu Financial (VIRT) Files $100M IPO
-
Post Holdings (POST) Announces $250M Senior Notes, 4M Common Offering
-
Competitor Data Positive for ISIS Pharmaceuticals (ISIS), BMO Capital Says
-
Notable Analyst Rating Changes 03/10: (BIG) (ADM) (X) Upgraded; (SPLS) (O) (TMHC) Downgraded
-
Regado Biosciences (RGDO) FDA Fast Track an 'Incramental Positive', BMO Capital
-
Arena Pharma (ARNA) BELVIQ TRx up 5.3%
-
BMO Capital Starts Flexion Therapeutics (FLXN) at Outperform
-
BMO Capital Upgrades Alcatel-Lucent (ALU) to Outperform
-
BMO Capital Upgrades Archer Daniels Midland (ADM) to Outperform
-
BMO Capital Upgrades AGL Resources Inc. (GAS) to Market Perform
-
Kroger (KR) Target, Estimates Bumped at Kroger
-
UPDATE: BMO Capital Upgrades Biogen (BIIB) to Outperform
-
Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded
-
BMO Capital Upgrades 21st Century Fox (FOXA) to Outperform
-
Notable Analyst Rating Changes 03/04: (ANF) (GTI) (CME) Upgraded; (AMBC) ISRG) (CLF) Downgraded
-
BMO Capital Starts Santander Consumer USA Holdings Inc. (SC) at Outperform
-
BMO Capital Starts Auspex Pharmaceuticals (ASPX) at Outperform
-
BMO Capital Upgrades Hudson Pacific Properties (HPP) to Market Perform
-
BMO Capital Downgrades Banro Corporation (BAA) to Underperform
-
BMO Capital Starts Revance Therapeutic (RVNC) at Outperform
-
BMO Capital Upgrades BrandyWine (BDN) to Outperform
-
Restaurant Order Platform GrubHub (GRUB) Files $100M IPO
-
BMO Capital Downgrades American Public Education (APEI) to Market Perform
-
Notable Analyst Rating Changes 02/26: (LNKD) (RRC) (ARIA) Upgraded; (PSA) (NIHD) (HUM) Downgraded

